# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 91-100 of 2194 results.
Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma
Status: Recruiting
Last Changed: Jul 31, 2020
First Received: Mar 19, 2020
Disease(s): Relapsed/Refractory Large B-cell Lymphoma
Intervention(s): Cyclophosphamide, Fludarabine, Lenzilumab, Axicabtagene Ciloleucel
Locations: Mayo Clinic, Rochester, Minnesota, United States
Columbia University Medical Center, New York, New York, United States
MD Anderson Cancer Center, Houston, Texas, United States
YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial
Status: Not yet recruiting
Last Changed: Aug 05, 2020
First Received: Aug 05, 2020
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): YY-20394
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma
Status: Completed
Last Changed: Sep 08, 2006
First Received: Aug 30, 2005
Disease(s): B-Cell Lymphoma
Intervention(s): Zevalin plus BEAM
Locations: Groupe d'Etude des Lymphomes de l'adulte, Mont-Godinne, Belgium
Hôpital Henri Mondor, Créteil, France
Hématologie CHU de Lille, Lille, France
Institut Curie, Paris, France
Hôpital Saint Louis, Paris, France
... and 5 other locations.
A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Sep 14, 2018
First Received: Jul 06, 2018
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Decitabine
Locations: Oncology Department of The First Affilliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Completed
Last Changed: Apr 20, 2017
First Received: Mar 15, 2016
Disease(s): Diffuse Large B-Cell Lymphoma
Locations: PH Associates - an OPen Health Company, Marlow, United Kingdom
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Aug 05, 2020
First Received: Sep 24, 2018
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Radiation Therapy
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Rochester James P. Wilmot Cancer Institute, Rochester, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
MD Anderson Cancer Center, Houston, Texas, United States
... and 6 other locations.
R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma
Status: Unknown status
Last Changed: Mar 05, 2013
First Received: Jan 19, 2011
Disease(s): Diffuse Large B-cell Lymphoma
Intervention(s): R-ESHAP
Locations: Fudan University Shanghai Cancer Center, Shanghai, China
Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma
Status: Completed
Last Changed: Mar 12, 2018
First Received: Jun 19, 2012
Disease(s): Diffuse Large B-cell Lymphoma
Intervention(s): Valproate, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone
Locations: Skåne University Hospital, Dept. of Oncology, Lund, Sweden
Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma
Status: Active, not recruiting
Last Changed: Mar 11, 2020
First Received: Nov 01, 2016
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Decitabine
Locations: Shanghai Ruijin Hospital, Shanghai, China
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
Status: Recruiting
Last Changed: Mar 13, 2020
First Received: Apr 07, 2017
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Biological samples collection
Locations: CHU Caen, Caen, France
Hopital Henri Mondor, Creteil, France
CHU Le Bocage, Dijon, France
CH Départemental, La Roche sur Yon, France
CHU Claude Hurriez, Lille, France
... and 11 other locations.